Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith enclose the Certificate issued by M/s. Link Intime India Private Limited, Registrar and Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of Securities & Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
This is to inform you that, Nomination and Remuneration Committee of the Board of Directors of the Company, via circular resolution dated October 10, 2023, have approved the allotment of 2,888 Equity shares of Rs. 2/- each, aggregating to Rs. 5,776 against the Restrictive Stock Units vested in and exercised by the employees of the Company under the MHL-Restrictive Stock Unit Plan, 2020.
Q2 performance: Metropolis Healthcare reports double digit growth, shares gain 2%
Q2 earnings: Core business revenue grew by 13 percent Year on Year, driven by volume growth, demonstrating strong customer acquisition. Metropolis Healthcare Ltd - 542650 - Intimation Of Vacation Of Registered Office Of The Company
We wish to you inform you that the company has vacated its Registered Office situated at 250 D, Udyog Bhavan Worli, Mumbai-400030. Presently, the Company is using its Corporate Office located at 4th floor, Commercial building 1 A, Kohinoor Mall, Vidyavihar (West), Mumbai - 400070 to carry out all the operations and business activities that were previously carried out at the Registered Office. Metropolis Healthcare Ltd - 542650 - Business Update For 2Nd Quarter Ended September 30, 2023
In accordance with the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations 2015, and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company would like to update on the key business parameters of the Company on a Consolidated basis for the quarter ended September 30, 2023 i.e. Q2FY24. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Credit Rating
We wish to inform you that CRISIL Ratings Limited ("CRISIL") has revised its outlook on the long-term bank facilities and Non-Convertible Debentures of the Company to ''Stable'' from ''Positive'' while maintaining rating at ''CRISIL AA-''. CRISIL has also reassigned short-term rating at ''CRISIL A1+'' on proposed working capital limits. The reports from CRISIL Ratings providing the rationale for revision in rating/ outlook is enclosed for reference. Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
This is to inform you that pursuant to the Company''s Code of Fair disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in Securities of the Company by the Designated Persons of the Company and/ or their immediate relatives will be closed with effect from October 01, 2023 and shall remain closed up to 48 (Forty-Eight) hours after the declaration of the Financial Results of the Company for the quarter and half year ending September 30, 2023. The date of the Board Meeting for approval of Financial Results of the Company for the quarter and half year ending September, 2023, shall be intimated in due course. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that the Company has published today, an advertisement in Free Press Journal (English Newspaper) & Navshakti (Marathi Newspaper) regarding the dispatch of Postal Ballot Notice. Metropolis Healthcare Ltd - 542650 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached Postal Ballot Notice dated August 02, 2023 seeking approval of the Members of the Company, by way of remote e-voting for appointment of Mr. Subramanian Ranganathan (DIN: 00125493) as a Non-Executive Independent Director of the Company. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) on September 26, 2023 at Kotak Healthcare Forum 2023 . Discussions will be based on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of the Participants/Host/Company.